Austral DX is a French MedTech startup founded in 2021 that develops contactless AI-powered technology for rapid cardiopulmonary diagnostics. The company’s innovative medical device uses airborne ultrasound to capture chest vibrations with sub-micron precision, enabling non-invasive, radiation-free assessment of heart and lung health in under two minutes. Designed for use in emergency care, hospitals, outpatient settings, and home environments, the technology aims to accelerate diagnosis of life-threatening conditions such as pulmonary embolism, pneumonia, and cardiac issues, thereby improving patient outcomes and streamlining healthcare pathways.